These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8254853)

  • 21. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
    Zhang W; Han L; Lin C; Wang H; Pang X; Li L; Gao P; Lin H; Gong X; Tang Y; Ma J; Zhang H; Wang C; Yang P; Li H; Sun M; He X
    Vaccine; 2011 Aug; 29(37):6276-82. PubMed ID: 21722684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of 5 and 10 microgram doses of two recombinant hepatitis B vaccines.
    Bryan JP; Craig PG; Reyes L; Hakre S; Jaramillo R; Harlan H; MacArthy P; Legters LJ
    Vaccine; 1995 Aug; 13(11):978-82. PubMed ID: 8525691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.
    Averhoff F; Mahoney F; Coleman P; Schatz G; Hurwitz E; Margolis H
    Am J Prev Med; 1998 Jul; 15(1):1-8. PubMed ID: 9651632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the immuno-effects of recombinant hepatitis B vaccination in adults].
    Zhang FM; Zhao QX; Han JH; Zhou QH; Wang MC; Miao W; Li R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug; 24(8):697-9. PubMed ID: 14521791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
    Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varying antibody response in dental health care workers vaccinated with recombinant hepatitis B vaccine.
    Aspinall S; Hauman CH; Bos P; Zulch RN
    J Dent Assoc S Afr; 1991 Jun; 46(6):321-4. PubMed ID: 1962318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response to hepatitis B vaccine in health-care workers.
    Zamani F; Fallahian F; Hashemi F; Shamsaei Z; Alavian SM
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):179-84. PubMed ID: 21196642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long term results of vaccination against viral hepatitis B using recombinant vaccine Engerix B].
    Juszczyk J; Barałkiewicz G
    Przegl Epidemiol; 1992; 46(4):271-9. PubMed ID: 1305775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders.
    Goldwater PN
    Vaccine; 1994 Apr; 12(5):410-4. PubMed ID: 8023548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
    Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel].
    Ricciardi G; Graziano G
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):385-90. PubMed ID: 2152297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.
    Vesikari T; Martin JC; Liss CL; Liska V; Schödel FP; Bhuyan PK
    Pediatr Infect Dis J; 2011 Jul; 30(7):e109-13. PubMed ID: 21552183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adaptability of the anti-hepatitis-B vaccine Recombivax HB to the Piazza protocol for the mass vaccination of newborn infants].
    Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):483-9. PubMed ID: 1482565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Demonstration of the interchangeability of 2 types of recombinant anti-hepatitis-B vaccine].
    Piazza M; Abrescia N; Picciotto L; Orlando R; Cerini R; Borgia G; Cotugno M
    Boll Soc Ital Biol Sper; 1993 Apr; 69(4):273-80. PubMed ID: 8129908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and Clinical Predictors of Nonresponse to Hepatitis B Vaccination among Patients Receiving Hemodialysis: Importance of Obesity.
    Patel N; Assimon MM; Bruni E; McNutt LA; Mason DL
    South Med J; 2015 Sep; 108(9):567-73. PubMed ID: 26332483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HBs antibody persistence following primary vaccination with an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency.
    Surquin M; Tielemans C; Nortier J; Jadoul M; Peeters P; Ryba M; Roznovsky L; Domán J; Barthelemy X; Crasta PD; Messier M; Houard S
    Hum Vaccin; 2011 Sep; 7(9):913-8. PubMed ID: 21892006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serologic hepatitis B immunity in vaccinated health care workers.
    Barash C; Conn MI; DiMarino AJ; Marzano J; Allen ML
    Arch Intern Med; 1999 Jul; 159(13):1481-3. PubMed ID: 10399900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States.
    Spradling PR; Williams RE; Xing J; Soyemi K; Towers J
    Infect Control Hosp Epidemiol; 2012 Jul; 33(7):732-6. PubMed ID: 22669236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.